Frequently asked questions about our innovations & clinical standard
Women have been asked to call too much of their suffering normal—from debilitating period pain and undiagnosed iron deficiency to severe obstetric perineal trauma and unresearched vaginal care. We focus on neglected, high-burden morbidities that shape how women live, work, recover, and care, engineering dignified solutions where clinical investment has historically lagged.
Context changes; the standard does not. We build for world-class quality, rigorous evidence, and genuine affordability simultaneously. Equity is never a lower specification, and local East African manufacture is not a compromise. Our technologies are engineered to belong in rural district hospitals while withstanding scrutiny in the world’s most demanding regulatory markets.
We listen before we design. Midwives, obstetricians, nurses, and women define the engineering problem before any prototype is milled or cast. Every device is engineered around the physical realities and workflows of maternity labor wards, eliminating reliance on stable electrical grids or delicate disposable consumables.
Listening to a mother leads directly to the newborn in her arms. A premature infant's respiratory crisis unfolds during the mother’s first hours of motherhood—her recovery, her bond, and her child. Standard surfactant therapy requires endotracheal intubation unavailable in most district wards; SawaSurf enables non-invasive delivery within the critical WHO 2-hour window.
We provide dedicated partnership doors for impact investors, catalytic grant funders, clinical trial institutions, and maternal health advocates. Whether co-designing multicenter trials, scaling regional cleanroom manufacturing, or deploying pilot interventions, reach out directly at info@sawazishamedtechlabs.com.